$NWBO
NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo

$nwbo Overview Financials Valuation SEC Filings Company Website

2013 Q3 Form 10-Q Financial Statement

#000114420413046070 Filed on August 14, 2013

Income Statement

Concept	2013 Q3	2013 Q2	2012 Q2
Revenue	$400.0K	$272.0K	$330.0K
YoY Change	233.33%	-17.58%
Cost Of Revenue		$0.00	$0.00
YoY Change
Gross Profit		$272.0K	$330.0K
YoY Change		-17.58%
Gross Profit Margin		100.0%	100.0%
Selling, General & Admin	$3.060M	$3.290M	$2.030M
YoY Change	-21.74%	62.07%	-63.49%
% of Gross Profit		1209.56%	615.15%
Research & Development	$12.79M	$8.383M	$7.040M
YoY Change	28.71%	19.08%	102.88%
% of Gross Profit		3081.99%	2133.33%
Depreciation & Amortization	$0.00	$10.00K	$0.00
YoY Change	-100.0%
% of Gross Profit		3.68%	0.0%
Operating Expenses	$12.79M	$8.383M	$7.040M
YoY Change	-7.69%	19.08%	-22.04%
Operating Profit	-$15.46M	-$11.40M	-$8.737M
YoY Change	12.49%	30.53%	-3.24%
Interest Expense	$66.00K	$190.0K	$1.613M
YoY Change	-97.63%	-88.22%	-194.33%
% of Operating Profit
Other Income/Expense, Net	-$7.450M	$0.00	$0.00
YoY Change			-100.0%
Pretax Income	-$22.91M	-$11.59M	-$10.15M
YoY Change	38.85%	14.19%	-17.68%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$22.91M	-$11.59M	-$10.15M
YoY Change	38.89%	14.23%	-17.68%
Net Earnings / Revenue	-5727.5%	-4262.5%	-3075.76%
Basic Earnings Per Share
Diluted Earnings Per Share	-$649.4K	-$398.1K	-$1.000M
COMMON SHARES
Basic Shares Outstanding	33.86M shares		162.8M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q3	2013 Q2	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.860M	$1.990M	$430.0K
YoY Change	2500.0%	362.79%	-93.58%
Cash & Equivalents	$2.857M	$1.985M	$430.0K
Short-Term Investments
Other Short-Term Assets	$4.640M	$360.0K	$260.0K
YoY Change	2342.11%	38.46%	271.43%
Inventory
Prepaid Expenses
Receivables			$200.0K
Other Receivables			$0.00
Total Short-Term Assets	$7.500M	$2.348M	$890.0K
YoY Change	2400.0%	163.82%	-86.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$140.0K	$89.00K	$100.0K
YoY Change	40.0%	-11.0%	150.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$0.00	$30.00K
YoY Change	-100.0%	-100.0%	50.0%
Total Long-Term Assets	$135.0K	$89.00K	$130.0K
YoY Change	3.85%	-31.54%	116.67%
TOTAL ASSETS
Total Short-Term Assets	$7.500M	$2.348M	$890.0K
Total Long-Term Assets	$135.0K	$89.00K	$130.0K
Total Assets	$7.635M	$2.437M	$1.020M
YoY Change	1675.58%	138.92%	-85.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.94M	$15.31M	$6.900M
YoY Change	33.86%	121.87%	-46.18%
Accrued Expenses	$1.170M	$1.088M	$4.440M
YoY Change	-85.71%	-75.5%	-5.93%
Deferred Revenue
YoY Change
Short-Term Debt	$930.0K	$930.0K	$0.00
YoY Change
Long-Term Debt Due	$670.0K	$1.340M	$18.95M
YoY Change	-96.61%	-92.93%	72.27%
Total Short-Term Liabilities	$17.22M	$18.67M	$30.33M
YoY Change	-52.37%	-38.43%	-40.4%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$1.340M
YoY Change	-100.0%	-100.0%	24.07%
Other Long-Term Liabilities	$4.720M
YoY Change
Total Long-Term Liabilities	$4.722M	$0.00	$1.340M
YoY Change	98.4%	-100.0%	24.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.22M	$18.67M	$30.33M
Total Long-Term Liabilities	$4.722M	$0.00	$1.340M
Total Liabilities	$21.94M	$18.67M	$31.68M
YoY Change	-43.05%	-41.05%	-39.05%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$343.1M	$318.0M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$25.08M	-$27.25M	-$30.66M
YoY Change
Total Liabilities & Shareholders Equity	$7.635M	$2.437M	$1.020M
YoY Change	1675.58%	138.92%	-85.07%

Cashflow Statement

Concept	2013 Q3	2013 Q2	2012 Q2
OPERATING ACTIVITIES
Net Income	-$22.91M	-$11.59M	-$10.15M
YoY Change	38.89%	14.23%	-17.68%
Depreciation, Depletion And Amortization	$0.00	$10.00K	$0.00
YoY Change	-100.0%
Cash From Operating Activities	-$7.920M	-$8.210M	-$4.830M
YoY Change	28.99%	69.98%	36.44%
INVESTING ACTIVITIES
Capital Expenditures	-$50.00K	$0.00	-$30.00K
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$4.500M	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$4.550M	$0.00	-$30.00K
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	13.34M	9.820M	5.260M
YoY Change	129.6%	86.69%	-43.32%
NET CHANGE
Cash From Operating Activities	-7.920M	-8.210M	-4.830M
Cash From Investing Activities	-4.550M	0.000	-30.00K
Cash From Financing Activities	13.34M	9.820M	5.260M
Net Change In Cash	870.0K	1.610M	400.0K
YoY Change	-363.64%	302.5%	-93.03%
FREE CASH FLOW
Cash From Operating Activities	-$7.920M	-$8.210M	-$4.830M
Capital Expenditures	-$50.00K	$0.00	-$30.00K
Free Cash Flow	-$7.870M	-$8.210M	-$4.800M
YoY Change	28.18%	71.04%	35.59%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
CY2013Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33861841	shares
	dei	Entity Registrant Name EntityRegistrantName	NORTHWEST BIOTHERAPEUTICS INC
	dei	Entity Central Index Key EntityCentralIndexKey	0001072379
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q2	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	10059000	USD
	dei	Trading Symbol TradingSymbol	NWBO
CY2012Q4	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	3397000	USD
CY2013Q2	nwbo	Accrued Expenses Related Party AccruedExpensesRelatedParty	4000	USD
CY2012Q4	nwbo	Accrued Expenses Related Party AccruedExpensesRelatedParty	28000	USD
CY2013Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	40000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	40000000	shares
CY2013Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30735966	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26545828	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30735966	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26545828	shares
CY2013Q2	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2013Q2	nwbo	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	50000	USD
	dei	Document Period End Date DocumentPeriodEndDate	2013-06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10589000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	409000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1219000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7346000	USD
CY2013Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	363000	USD
CY2012Q4	nwbo	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	50000	USD
CY2013Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1869770	shares
CY2012Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1869770	shares
CY2013Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1869770	shares
CY2012Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1869770	shares
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1985000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	112000	USD
CY2013Q2	us-gaap	Assets Current AssetsCurrent	2348000	USD
	nwbo	Contract Research And Development From Related Parties ContractResearchAndDevelopmentFromRelatedParties	1128000	USD
	nwbo	Research Grants And Other ResearchGrantsAndOther	409000	USD
	nwbo	Research Grants And Other ResearchGrantsAndOther	330000	USD
	nwbo	Research Grants And Other ResearchGrantsAndOther	2242000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	330000	USD
	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0	USD
	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	3950000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	0	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	0	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	382000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19991000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	139163000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5760000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4239000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	96759000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2383000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	0	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	0	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	580000	USD
	nwbo	Contract Research And Development From Related Parties ContractResearchAndDevelopmentFromRelatedParties	0	USD
	nwbo	Contract Research And Development From Related Parties ContractResearchAndDevelopmentFromRelatedParties	0	USD
	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	-895000	USD
	nwbo	Asset Impairment Loss And Other Gain Loss AssetImpairmentLossAndOtherGainLoss	0	USD
	nwbo	Asset Impairment Loss And Other Gain Loss AssetImpairmentLossAndOtherGainLoss	0	USD
	nwbo	Asset Impairment Loss And Other Gain Loss AssetImpairmentLossAndOtherGainLoss	2445000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	25757000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	14832000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	242027000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	7458000	USD
CY2013Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	60000	USD
CY2012Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	60000	USD
CY2013Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	171000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	172000	USD
CY2013Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	142000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	137000	USD
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	89000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	95000	USD
CY2013Q2	nwbo	Deposits And Other Noncurrent Assets DepositsAndOtherNoncurrentAssets	0	USD
CY2012Q4	nwbo	Deposits And Other Noncurrent Assets DepositsAndOtherNoncurrentAssets	17000	USD
CY2013Q2	us-gaap	Assets Assets	2437000	USD
CY2012Q4	us-gaap	Assets Assets	7570000	USD
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	15309000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8165000	USD
CY2013Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1088000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	589000	USD
CY2013Q2	us-gaap	Notes Payable NotesPayable	934000	USD
CY2012Q4	us-gaap	Notes Payable NotesPayable	934000	USD
CY2013Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1343000	USD
CY2012Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1056000	USD
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	18674000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10744000	USD
CY2013Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	USD
CY2012Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1882000	USD
CY2013Q2	us-gaap	Liabilities Liabilities	18674000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	12626000	USD
CY2013Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	11017000	USD
CY2012Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	11017000	USD
CY2013Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	31000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	27000	USD
CY2013Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	317991000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	303188000	USD
CY2013Q2	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	345086000	USD
CY2012Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	319098000	USD
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-190000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-190000	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	-27254000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	-16073000	USD
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2437000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7570000	USD
CY2013Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	0	USD
CY2012Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	0	USD
CY2013Q2	nwbo	Contract Research And Development From Related Parties ContractResearchAndDevelopmentFromRelatedParties	0	USD
CY2012Q2	nwbo	Contract Research And Development From Related Parties ContractResearchAndDevelopmentFromRelatedParties	0	USD
CY2013Q2	nwbo	Research Grants And Other ResearchGrantsAndOther	272000	USD
CY2012Q2	nwbo	Research Grants And Other ResearchGrantsAndOther	330000	USD
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	272000	USD
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	330000	USD
CY2013Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	0	USD
CY2012Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	0	USD
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8383000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-25348000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14502000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-238077000	USD
	nwbo	Valuation Of Reclassified Equity Contracts ValuationOfReclassifiedEquityContracts	-491000	USD
	nwbo	Valuation Of Reclassified Equity Contracts ValuationOfReclassifiedEquityContracts	-16071000	USD
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	0	USD
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	0	USD
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	27337000	USD
	nwbo	Accretion Of Redeemable Securities AccretionOfRedeemableSecurities	0	USD
	nwbo	Accretion Of Redeemable Securities AccretionOfRedeemableSecurities	0	USD
	nwbo	Accretion Of Redeemable Securities AccretionOfRedeemableSecurities	2042000	USD
CY2013Q2	nwbo	Gain Loss On Sale Of Intellectual Property And Property And Equipment GainLossOnSaleOfIntellectualPropertyAndPropertyAndEquipment	0	USD
CY2012Q2	nwbo	Gain Loss On Sale Of Intellectual Property And Property And Equipment GainLossOnSaleOfIntellectualPropertyAndPropertyAndEquipment	0	USD
CY2013Q2	us-gaap	Interest Expense InterestExpense	190000	USD
CY2013Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	0	USD
CY2012Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	0	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-11594000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-10150000	USD
CY2013Q2	nwbo	Issuance Of Common Stock In Connection With Elimination Of Preferred Stock IssuanceOfCommonStockInConnectionWithEliminationOfPreferredStock	0	USD
CY2012Q2	nwbo	Issuance Of Common Stock In Connection With Elimination Of Preferred Stock IssuanceOfCommonStockInConnectionWithEliminationOfPreferredStock	0	USD
	nwbo	Issuance Of Common Stock In Connection With Elimination Of Preferred Stock IssuanceOfCommonStockInConnectionWithEliminationOfPreferredStock	0	USD
	nwbo	Issuance Of Common Stock In Connection With Elimination Of Preferred Stock IssuanceOfCommonStockInConnectionWithEliminationOfPreferredStock	12349000	USD
CY2013Q2	nwbo	Warrants Issued On Preferred Stock WarrantsIssuedOnPreferredStock	0	USD
CY2012Q2	nwbo	Warrants Issued On Preferred Stock WarrantsIssuedOnPreferredStock	0	USD
	nwbo	Warrants Issued On Preferred Stock WarrantsIssuedOnPreferredStock	0	USD
	nwbo	Warrants Issued On Preferred Stock WarrantsIssuedOnPreferredStock	0	USD
	nwbo	Warrants Issued On Preferred Stock WarrantsIssuedOnPreferredStock	4664000	USD
CY2013Q2	nwbo	Accretion Of Preferred Stock Mandatory Redemption Obligation AccretionOfPreferredStockMandatoryRedemptionObligation	0	USD
CY2012Q2	nwbo	Accretion Of Preferred Stock Mandatory Redemption Obligation AccretionOfPreferredStockMandatoryRedemptionObligation	0	USD
	nwbo	Accretion Of Preferred Stock Mandatory Redemption Obligation AccretionOfPreferredStockMandatoryRedemptionObligation	0	USD
	nwbo	Accretion Of Preferred Stock Mandatory Redemption Obligation AccretionOfPreferredStockMandatoryRedemptionObligation	0	USD
	nwbo	Accretion Of Preferred Stock Mandatory Redemption Obligation AccretionOfPreferredStockMandatoryRedemptionObligation	1872000	USD
CY2012Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7040000	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3290000	USD
CY2012Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2025000	USD
CY2013Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3000	USD
CY2012Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2000	USD
CY2013Q2	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0	USD
CY2012Q2	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0	USD
CY2013Q2	nwbo	Asset Impairment Loss And Other Gain Loss AssetImpairmentLossAndOtherGainLoss	0	USD
CY2012Q2	nwbo	Asset Impairment Loss And Other Gain Loss AssetImpairmentLossAndOtherGainLoss	0	USD
CY2013Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	11676000	USD
CY2012Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	9067000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-11404000	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-8737000	USD
CY2013Q2	nwbo	Valuation Of Reclassified Equity Contracts ValuationOfReclassifiedEquityContracts	0	USD
CY2012Q2	nwbo	Valuation Of Reclassified Equity Contracts ValuationOfReclassifiedEquityContracts	0	USD
	nwbo	Valuation Of Reclassified Equity Contracts ValuationOfReclassifiedEquityContracts	0	USD
CY2013Q2	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	0	USD
CY2012Q2	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	0	USD
CY2013Q2	nwbo	Accretion Of Redeemable Securities AccretionOfRedeemableSecurities	0	USD
CY2012Q2	nwbo	Accretion Of Redeemable Securities AccretionOfRedeemableSecurities	0	USD
CY2013Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	USD
CY2012Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	200000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	548000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1383000	USD
	nwbo	Gain Loss On Sale Of Intellectual Property And Property And Equipment GainLossOnSaleOfIntellectualPropertyAndPropertyAndEquipment	0	USD
	nwbo	Gain Loss On Sale Of Intellectual Property And Property And Equipment GainLossOnSaleOfIntellectualPropertyAndPropertyAndEquipment	0	USD
	nwbo	Gain Loss On Sale Of Intellectual Property And Property And Equipment GainLossOnSaleOfIntellectualPropertyAndPropertyAndEquipment	3664000	USD
CY2012Q2	us-gaap	Interest Expense InterestExpense	1613000	USD
	us-gaap	Interest Expense InterestExpense	640000	USD
	us-gaap	Interest Expense InterestExpense	6838000	USD
	us-gaap	Interest Expense InterestExpense	55646000	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	0	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	0	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	1707000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-25988000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-20301000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-300277000	USD
	nwbo	Issuance Of Common Stock In Connection With Elimination Of Preferred Stock IssuanceOfCommonStockInConnectionWithEliminationOfPreferredStock	0	USD
CY2013Q2	nwbo	Preferred Stock Redemption Fee PreferredStockRedemptionFee	0	USD
CY2012Q2	nwbo	Preferred Stock Redemption Fee PreferredStockRedemptionFee	0	USD
	nwbo	Preferred Stock Redemption Fee PreferredStockRedemptionFee	0	USD
	nwbo	Preferred Stock Redemption Fee PreferredStockRedemptionFee	0	USD
	nwbo	Preferred Stock Redemption Fee PreferredStockRedemptionFee	1700000	USD
CY2013Q2	nwbo	Beneficial Conversion Feature Of Preferred Stock BeneficialConversionFeatureOfPreferredStock	0	USD
CY2012Q2	nwbo	Beneficial Conversion Feature Of Preferred Stock BeneficialConversionFeatureOfPreferredStock	0	USD
	nwbo	Beneficial Conversion Feature Of Preferred Stock BeneficialConversionFeatureOfPreferredStock	0	USD
	nwbo	Beneficial Conversion Feature Of Preferred Stock BeneficialConversionFeatureOfPreferredStock	0	USD
	nwbo	Beneficial Conversion Feature Of Preferred Stock BeneficialConversionFeatureOfPreferredStock	4274000	USD
CY2013Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11594000	USD
CY2012Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10150000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25988000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20301000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-345086000	USD
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.40
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.93
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
CY2013Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	29105000	shares
CY2012Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	162357000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	28078000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	157869000	shares
CY2013Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	40000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	190000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-11594000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-10150000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-25988000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-20341000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-345276000	USD
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	6000	USD
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	4000	USD
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	2383000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	320000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	482000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6016000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	44727000	USD
	nwbo	Accrued Interest Converted To Preferred Stock AccruedInterestConvertedToPreferredStock	0	USD
	nwbo	Accrued Interest Converted To Preferred Stock AccruedInterestConvertedToPreferredStock	0	USD
	nwbo	Accrued Interest Converted To Preferred Stock AccruedInterestConvertedToPreferredStock	260000	USD
	nwbo	Accreted Interest On Convertible Promissory Note AccretedInterestOnConvertiblePromissoryNote	61000	USD
	nwbo	Accreted Interest On Convertible Promissory Note AccretedInterestOnConvertiblePromissoryNote	0	USD
	nwbo	Accreted Interest On Convertible Promissory Note AccretedInterestOnConvertiblePromissoryNote	1545000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1897000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	24281000	USD
	nwbo	Stock And Warrants Issued For Services And Other Expenses StockAndWarrantsIssuedForServicesAndOtherExpenses	1528000	USD
	nwbo	Stock And Warrants Issued For Services And Other Expenses StockAndWarrantsIssuedForServicesAndOtherExpenses	0	USD
	nwbo	Stock And Warrants Issued For Services And Other Expenses StockAndWarrantsIssuedForServicesAndOtherExpenses	25482000	USD
	nwbo	Loan Conversion Inducement Expense LoanConversionInducementExpense	0	USD
	nwbo	Loan Conversion Inducement Expense LoanConversionInducementExpense	0	USD
	nwbo	Loan Conversion Inducement Expense LoanConversionInducementExpense	19518000	USD
	nwbo	Asset Impairment Loss And Gain Loss On Sale Of Properties AssetImpairmentLossAndGainLossOnSaleOfProperties	0	USD
	nwbo	Asset Impairment Loss And Gain Loss On Sale Of Properties AssetImpairmentLossAndGainLossOnSaleOfProperties	0	USD
	nwbo	Asset Impairment Loss And Gain Loss On Sale Of Properties AssetImpairmentLossAndGainLossOnSaleOfProperties	-936000	USD
	nwbo	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	251000	USD
	nwbo	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	166000	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	90000	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	1251000	USD
	nwbo	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-347000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1005000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	5427000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	8728000	USD
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	6638000	USD
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	0	USD
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	34782000	USD
	nwbo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	-17000	USD
	nwbo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	17000	USD
	nwbo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	-16000	USD
	nwbo	Accrued Loss On Sublease AccruedLossOnSublease	0	USD
	nwbo	Accrued Loss On Sublease AccruedLossOnSublease	0	USD
	nwbo	Accrued Loss On Sublease AccruedLossOnSublease	-265000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	410000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15283000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8374000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-155237000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5124000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	258000	USD
	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	0	USD
	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	0	USD
	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	1816000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	2000000	USD
	nwbo	Payments For Refund Of Security Deposit PaymentsForRefundOfSecurityDeposit	0	USD
	nwbo	Payments For Refund Of Security Deposit PaymentsForRefundOfSecurityDeposit	0	USD
	nwbo	Payments For Refund Of Security Deposit PaymentsForRefundOfSecurityDeposit	3000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	1035000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2088000	USD
	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	0	USD
	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	0	USD
	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	5302000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	400000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	8500000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	8380000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	38414000	USD
	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties	0	USD
	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties	0	USD
	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties	11250000	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	8050000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	2834000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3262000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	2834000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	0	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	0	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	323000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	688000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1108000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	28708000	USD
	nwbo	Proceeds From Exercise Of Stock Options And Warrants ProceedsFromExerciseOfStockOptionsAndWarrants	0	USD
	nwbo	Proceeds From Exercise Of Stock Options And Warrants ProceedsFromExerciseOfStockOptionsAndWarrants	0	USD
	nwbo	Proceeds From Exercise Of Stock Options And Warrants ProceedsFromExerciseOfStockOptionsAndWarrants	228000	USD
	nwbo	Proceeds From Issuance Of Capital Stock ProceedsFromIssuanceOfCapitalStock	10210000	USD
	nwbo	Proceeds From Issuance Of Capital Stock ProceedsFromIssuanceOfCapitalStock	347000	USD
	nwbo	Proceeds From Issuance Of Capital Stock ProceedsFromIssuanceOfCapitalStock	83933000	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	320000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9922000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8847000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	159500000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-40000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-190000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-5361000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	406000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1985000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24000	USD
CY1996Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	430000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	195000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
	nwbo	Conversion Of Debt To Accounts Payable ConversionOfDebtToAccountsPayable	0	USD
	nwbo	Conversion Of Debt To Accounts Payable ConversionOfDebtToAccountsPayable	0	USD
	nwbo	Conversion Of Debt To Accounts Payable ConversionOfDebtToAccountsPayable	1428000	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Interest Paid InterestPaid	1879000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	285000	USD
	nwbo	Issuance Of Common Stock In Connection Conversion Of Notes Payable And Accrued Interest IssuanceOfCommonStockInConnectionConversionOfNotesPayableAndAccruedInterest	1850000	USD
	nwbo	Issuance Of Common Stock In Connection Conversion Of Notes Payable And Accrued Interest IssuanceOfCommonStockInConnectionConversionOfNotesPayableAndAccruedInterest	4658000	USD
	nwbo	Issuance Of Common Stock In Connection Conversion Of Notes Payable And Accrued Interest IssuanceOfCommonStockInConnectionConversionOfNotesPayableAndAccruedInterest	61032000	USD
	nwbo	Proceeds From Issuance Of Redeemable Common Stock ProceedsFromIssuanceOfRedeemableCommonStock	0	USD
	nwbo	Proceeds From Issuance Of Redeemable Common Stock ProceedsFromIssuanceOfRedeemableCommonStock	0	USD
	nwbo	Proceeds From Issuance Of Redeemable Common Stock ProceedsFromIssuanceOfRedeemableCommonStock	3673000	USD
	nwbo	Liability For Reclassified Equity Contracts LiabilityForReclassifiedEquityContracts	0	USD
	nwbo	Liability For Reclassified Equity Contracts LiabilityForReclassifiedEquityContracts	29412000	USD
	nwbo	Liability For Reclassified Equity Contracts LiabilityForReclassifiedEquityContracts	41253000	USD
	nwbo	Debt Discount On Promissory Notes DebtDiscountOnPromissoryNotes	0	USD
	nwbo	Debt Discount On Promissory Notes DebtDiscountOnPromissoryNotes	5520000	USD
	nwbo	Debt Discount On Promissory Notes DebtDiscountOnPromissoryNotes	27414000	USD
	nwbo	Issuance Of Preferred Stock Warrants In Connection With Lease Agreement IssuanceOfPreferredStockWarrantsInConnectionWithLeaseAgreement	0	USD
	nwbo	Issuance Of Preferred Stock Warrants In Connection With Lease Agreement IssuanceOfPreferredStockWarrantsInConnectionWithLeaseAgreement	0	USD
	nwbo	Issuance Of Preferred Stock Warrants In Connection With Lease Agreement IssuanceOfPreferredStockWarrantsInConnectionWithLeaseAgreement	43000	USD
	nwbo	Issuance Of Common Stock To Settle Accounts Payable IssuanceOfCommonStockToSettleAccountsPayable	0	USD
	nwbo	Issuance Of Common Stock To Settle Accounts Payable IssuanceOfCommonStockToSettleAccountsPayable	0	USD
	nwbo	Issuance Of Common Stock To Settle Accounts Payable IssuanceOfCommonStockToSettleAccountsPayable	4000	USD
	nwbo	Liability For And Issuance Of Common Stock And Warrants LiabilityForAndIssuanceOfCommonStockAndWarrants	0	USD
	nwbo	Liability For And Issuance Of Common Stock And Warrants LiabilityForAndIssuanceOfCommonStockAndWarrants	0	USD
	nwbo	Liability For And Issuance Of Common Stock And Warrants LiabilityForAndIssuanceOfCommonStockAndWarrants	840000	USD
	nwbo	Issuance Of Common Stock To Landlord IssuanceOfCommonStockToLandlord	0	USD
	nwbo	Issuance Of Common Stock To Landlord IssuanceOfCommonStockToLandlord	0	USD
	nwbo	Issuance Of Common Stock To Landlord IssuanceOfCommonStockToLandlord	35000	USD
	nwbo	Deferred Compensation On Issuance Of Stock Options And Restricted Stock Grants DeferredCompensationOnIssuanceOfStockOptionsAndRestrictedStockGrants	0	USD
	nwbo	Deferred Compensation On Issuance Of Stock Options And Restricted Stock Grants DeferredCompensationOnIssuanceOfStockOptionsAndRestrictedStockGrants	0	USD
	nwbo	Deferred Compensation On Issuance Of Stock Options And Restricted Stock Grants DeferredCompensationOnIssuanceOfStockOptionsAndRestrictedStockGrants	759000	USD
	nwbo	Cancellation Of Options And Restricted Stock CancellationOfOptionsAndRestrictedStock	0	USD
	nwbo	Cancellation Of Options And Restricted Stock CancellationOfOptionsAndRestrictedStock	0	USD
	nwbo	Cancellation Of Options And Restricted Stock CancellationOfOptionsAndRestrictedStock	849000	USD
	nwbo	Financing Of Prepaid Insurance Through Note Payable FinancingOfPrepaidInsuranceThroughNotePayable	0	USD
	nwbo	Financing Of Prepaid Insurance Through Note Payable FinancingOfPrepaidInsuranceThroughNotePayable	0	USD
	nwbo	Financing Of Prepaid Insurance Through Note Payable FinancingOfPrepaidInsuranceThroughNotePayable	491000	USD
	nwbo	Stock Subscription Receivable StockSubscriptionReceivable	0	USD
	nwbo	Stock Subscription Receivable StockSubscriptionReceivable	0	USD
	nwbo	Stock Subscription Receivable StockSubscriptionReceivable	480000	USD
	nwbo	Conversion Of Convertible Promissory Notes And Accrued Interest To Stock ConversionOfConvertiblePromissoryNotesAndAccruedInterestToStock	0	USD
	nwbo	Conversion Of Convertible Promissory Notes And Accrued Interest To Stock ConversionOfConvertiblePromissoryNotesAndAccruedInterestToStock	0	USD
	nwbo	Conversion Of Convertible Promissory Notes And Accrued Interest To Stock ConversionOfConvertiblePromissoryNotesAndAccruedInterestToStock	269000	USD
CY2013Q2	nwbo	Working Capital Deficit WorkingCapitalDeficit	16300000	USD
CY2013Q2	us-gaap	Temporary Equity Redemption Value TemporaryEquityRedemptionValue	11000000	USD
CY2013Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	10000000	USD
CY2013Q2	nwbo	Common Stock Closing Market Price CommonStockClosingMarketPrice	3.90
CY2013Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2564103	shares
CY2013Q2	nwbo	Number Of Common Stock Warrants Exercisable NumberOfCommonStockWarrantsExercisable	1025641	shares
CY2013Q2	invest	Investment Warrants Exercise Price InvestmentWarrantsExercisePrice	4.29
CY2013Q2	nwbo	Past Due PastDue	0	USD
CY2012Q2	nwbo	Government Grant GovernmentGrant	5500000	USD
CY2013Q2	nwbo	Net Proceeds From Issuance Of Warrants NetProceedsFromIssuanceOfWarrants	9200000	USD
	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	155200000	USD
	us-gaap	Stock Issued During Period Value Issued For Noncash Considerations StockIssuedDuringPeriodValueIssuedForNoncashConsiderations	189900000	USD
CY2013Q2	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	10000000	USD
	nwbo	Percentage Of Due To Related Parties PercentageOfDueToRelatedParties	0.62	pure
CY2013Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	610000	USD
CY2012Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	855000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1219000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1897000	USD
CY2011Q4	nwbo	Reclassified Equity Contracts Shares ReclassifiedEquityContractsShares	6800000	shares
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0018	pure
CY2013Q1	nwbo	Reclassified Equity Contracts ReclassifiedEquityContracts	0	USD
CY2012Q1	nwbo	Reclassified Equity Contracts ReclassifiedEquityContracts	253000	USD
CY2012Q4	nwbo	Reclassified Equity Contracts ReclassifiedEquityContracts	0	USD
CY2011Q4	nwbo	Reclassified Equity Contracts ReclassifiedEquityContracts	601000	USD
CY2013Q2	nwbo	Liabilities Reclassified LiabilitiesReclassified	0	USD
CY2012Q2	nwbo	Liabilities Reclassified LiabilitiesReclassified	0	USD
	nwbo	Liabilities Reclassified LiabilitiesReclassified	0	USD
	nwbo	Liabilities Reclassified LiabilitiesReclassified	0	USD
CY2013Q2	nwbo	Gain Loss On Liabilities Reclassification GainLossOnLiabilitiesReclassification	0	USD
CY2012Q2	nwbo	Gain Loss On Liabilities Reclassification GainLossOnLiabilitiesReclassification	0	USD
	nwbo	Gain Loss On Liabilities Reclassification GainLossOnLiabilitiesReclassification	0	USD
	nwbo	Gain Loss On Liabilities Reclassification GainLossOnLiabilitiesReclassification	0	USD
CY2013Q2	nwbo	Liabilities Reclassified To Equity Contracts LiabilitiesReclassifiedToEquityContracts	0	USD
CY2012Q2	nwbo	Liabilities Reclassified To Equity Contracts LiabilitiesReclassifiedToEquityContracts	200000	USD
	nwbo	Liabilities Reclassified To Equity Contracts LiabilitiesReclassifiedToEquityContracts	0	USD
	nwbo	Liabilities Reclassified To Equity Contracts LiabilitiesReclassifiedToEquityContracts	548000	USD
CY2013Q2	nwbo	Reclassified Equity Contracts ReclassifiedEquityContracts	0	USD
CY2012Q2	nwbo	Reclassified Equity Contracts ReclassifiedEquityContracts	53000	USD
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	1900000	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	3700000	USD
	nwbo	Proceeds From Issuance Of Convertible Promissory Note And Warrants Net Of Issuance Costs ProceedsFromIssuanceOfConvertiblePromissoryNoteAndWarrantsNetOfIssuanceCosts	400000	USD
	nwbo	Proceeds From Issuance Of Convertible Promissory Note And Warrants Net Of Issuance Costs ProceedsFromIssuanceOfConvertiblePromissoryNoteAndWarrantsNetOfIssuanceCosts	8500000	USD
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	700000	shares
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	600000	shares
	nwbo	Repayments Of Convertible Notes Payable RepaymentsOfConvertibleNotesPayable	700000	USD
	nwbo	Debt Discount Convertible Beneficial Conversion Feature For Convertible Notes And Detachable Warrants DebtDiscountConvertibleBeneficialConversionFeatureForConvertibleNotesAndDetachableWarrants	3200000	USD
	nwbo	Debt Discount Convertible Beneficial Conversion Feature For Convertible Notes And Detachable Warrants DebtDiscountConvertibleBeneficialConversionFeatureForConvertibleNotesAndDetachableWarrants	0	USD
CY2013Q2	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	934000	USD
CY2012Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	934000	USD
CY2013Q2	nwbo	Other Convertible Notes Payable Current OtherConvertibleNotesPayableCurrent	468000	USD
CY2012Q4	nwbo	Other Convertible Notes Payable Current OtherConvertibleNotesPayableCurrent	1006000	USD
CY2013Q2	nwbo	Convertible Notes Payable Current Related Parties ConvertibleNotesPayableCurrentRelatedParties	875000	USD
CY2012Q4	nwbo	Convertible Notes Payable Current Related Parties ConvertibleNotesPayableCurrentRelatedParties	50000	USD
CY2013Q2	us-gaap	Notes Payable Current NotesPayableCurrent	2277000	USD
CY2012Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3872000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14925000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9183000	shares
CY2013Q2	us-gaap	Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross	5200000	USD
CY2012Q2	us-gaap	Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross	3800000	USD
	us-gaap	Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross	14200000	USD
	us-gaap	Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross	6000000	USD
CY2013Q2	nwbo	Research And Development Expense Service Agreement ResearchAndDevelopmentExpenseServiceAgreement	10000000	USD
CY2012Q4	nwbo	Research And Development Expense Service Agreement ResearchAndDevelopmentExpenseServiceAgreement	1800000	USD
CY2013Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	595000	shares
CY2013Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3595000	shares
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	4190000	shares
CY2013Q1	nwbo	Stock Issued During Period New Issues Price Per Share StockIssuedDuringPeriodNewIssuesPricePerShare	3.06
CY2013Q2	nwbo	Stock Issued During Period New Issues Price Per Share StockIssuedDuringPeriodNewIssuesPricePerShare	3.49
	nwbo	Stock Issued During Period New Issues Price Per Share StockIssuedDuringPeriodNewIssuesPricePerShare	3.43
CY2013Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1817000	USD
CY2013Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	12561000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14378000	USD
CY2012Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	12086501	shares
CY2013Q1	nwbo	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	109035	shares
CY2013Q1	nwbo	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	18125	shares
CY2013Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	12177411	shares
CY2012Q4	nwbo	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	6.81
CY2013Q1	nwbo	Class Of Warrant Or Right Issued Weighted Average Exercise Price ClassOfWarrantOrRightIssuedWeightedAverageExercisePrice	6.40
CY2013Q1	nwbo	Class Of Warrant Or Right Expired Weighted Average Exercise Price ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice	15.45
CY2013Q1	nwbo	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	6.82
CY2013Q2	nwbo	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	1153846	shares
CY2013Q2	nwbo	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	17500	shares
CY2013Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	13145403	shares
CY2013Q2	nwbo	Class Of Warrant Or Right Issued Weighted Average Exercise Price ClassOfWarrantOrRightIssuedWeightedAverageExercisePrice	4.29
CY2013Q2	nwbo	Class Of Warrant Or Right Expired Weighted Average Exercise Price ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice	12.00
CY2013Q2	nwbo	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	6.78
CY2013Q2	nwbo	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	168354	shares
CY2013Q2	nwbo	Class Of Warrant Or Right Exercised Weighted Average Exercise Price ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice	5.60
	nwbo	Cash Consideration Per Share CashConsiderationPerShare	4.00

Files In Submission

Name	View Source	Status
0001144204-13-046070-index-headers.html	Edgar Link	pending
0001144204-13-046070-index.html	Edgar Link	pending
0001144204-13-046070.txt	Edgar Link	pending
0001144204-13-046070-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
nwbo-20130630.xml	Edgar Link	completed
nwbo-20130630.xsd	Edgar Link	pending
nwbo-20130630_cal.xml	Edgar Link	unprocessable
nwbo-20130630_def.xml	Edgar Link	unprocessable
nwbo-20130630_lab.xml	Edgar Link	unprocessable
nwbo-20130630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v351889_10q.htm	Edgar Link	pending
v351889_ex31-1.htm	Edgar Link	pending
v351889_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NWBO
NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo

2013 Q3 Form 10-Q Financial Statement

#000114420413046070 Filed on August 14, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NWBO NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo

2013 Q3 Form 10-Q Financial Statement

#000114420413046070 Filed on August 14, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NWBO
NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo